Aerospace center hospital
Aerospace center hospital
Beijing, China5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, leiomyoma, myomatous neoplasm, neoplasm | Not yet recruiting | Not applicable | 2026-08-10 | NCT07754877 | |
| Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, adenomyosis, female reproductive system disorder, uterine disorder | Active, not recruiting | Not applicable | 2026-08-03 | NCT06751264 | |
| Individualized Open Lung Ventilation and Postoperative Pulmonary Complications in Thoracic Surgery | One-lung Ventilation (OLV); Postoperative Pulmonary Complications (PPCs); Thoracic Surgery, Video Assisted | Not yet recruiting | Not applicable | 2026-02-04 | NCT07387822 | |
| Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium | Confusion, Emergence Delirium, Neoplasms by Histologic Type, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, adenocarcinoma, carcinoma, cognitive disorder, cystic, mucinous, and serous neoplasm, delirium, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, nervous system disorder, pseudomyxoma peritonei, psychiatric disorder | Not yet recruiting | Not applicable | 2026-01-30 | NCT07378371 | |
| Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants | endocrine exophthalmos | Enrolling by invitation | Phase 1 | 2025-09-19 | NCT07182552 |